Shukra Pharmaceuticals Ltd.

Financial

	Shukra Pharma	Venus Remedies	Jenburkt Pharma
Operational Metrics
Financials
5 yr Average ROE	11.12 %	6.64 %	18.49 %
5yr average Equity Multiplier	2.18	1.46	1.17
5yr Average Asset Turnover Ratio	0.6	0.89	0.88
5yr Avg Net Profit Margin	7.6 %	4.93 %	18.1 %
Price to Book	9.39	1.03	3.31
P/E	61.65	12.68	17.74
5yr Avg Cash Conversion Cycle	-20.3 Days	72.13 Days	-32.02 Days
Inventory Days	31.54 Days	93.66 Days	24.72 Days
Days Receivable	133.87 Days	47.69 Days	48.38 Days
Days Payable	381.54 Days	52.51 Days	82.6 Days
5yr Average Interest Coverage Ratio	36.02	176.34	87.2
5yr Avg ROCE	10.67 %	6.96 %	24.44 %
5yr Avg Operating Profit Margin	15.03 %	10.58 %	22.46 %
5 yr average Debt to Equity	0.32	0.22	0.02
5yr CAGR Net Profit	241.36 %	n/a	14.21 %
5yr Average Return on Assets	6.5 %	5.11 %	15.8 %
Shareholdings
Promoter Holding	50.96 %	41.76 %	46.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.79 %	0.95 %	0.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Shukra Pharma	Venus Remedies	Jenburkt Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Dermatology 0	Product Wise Break-Up Pharmaceuticals 100.0 Dermatology 0	Product Wise Break-Up Pharmaceutical 100.0 Dermatology 0